utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
Published 7 months ago • 92 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
2:05
immunotherapy in breast cancer
-
5:34
neos: prognosis of er breast cancer pts who received neoadjuvant et with/without adjuvant chemo
-
3:09
advances in utilizing neoadjuvant immunotherapy in melanoma
-
1:23
latest advances in immuno-oncology research in er breast cancer
-
1:08
the role of immunotherapy in endocrine-refractory luminal breast cancer
-
7:15
characterizing the immune microenvironment before and following anti-her2 neoadjuvant therapy
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
4:53
comparing therapy benefit from initially her2 positive or negative metastatic breast cancer patients
-
2:31
adjuvant/neoadjuvant therapy trials for breast cancer at sabcs 2021
-
0:57
neohip: neoadjuvant her2-targeted therapy /- io with pembrolizumab
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
1:56
next questions in breast cancer treatment
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers